Psilocybin Therapy

Type: drug

Status: Australia: Approved. FDA: Rejected MDMA; psilocybin ongoing.

Developer: COMPASS Pathways/Usona

Breakthrough Summary

No summary available.

Mechanism of Action

Serotonin 2A agonist psychedelic with assisted psychotherapy

Year: 2024-2026